Literature DB >> 20515073

ITIH3 is a potential biomarker for early detection of gastric cancer.

Poh Kuan Chong1, Huiyin Lee, Jianbiao Zhou, Shaw-Cheng Liu, Marie Chiew Shia Loh, Ting Ting Wang, Siew Pang Chan, Duane T Smoot, Hassan Ashktorab, Jimmy Bok Yan So, Khong Hee Lim, Khay Guan Yeoh, Yoon Pin Lim.   

Abstract

Gastric cancer has one of the highest morbidities and mortalities worldwide. Early detection is key measure to improve the outcome of gastric cancer patients. In our efforts to identify potential markers for gastric cancer detection, we coupled xenotransplantation mouse model with a plasma proteomic approach. MKN45 gastric cancer cells were subcutaneously injected into nude mice and plasma samples from mice bearing different sizes of tumors were collected and subjected to iTRAQ and mass spectrometry analysis. ITIH3 protein was found to be more highly expressed in plasma of tumor bearing mice compared to control. Subsequent screening of ITIH3 expression in 167 clinical plasma samples, including 83 cancer-free subjects and 84 gastric cancer patients, revealed higher ITIH3 level in the plasma of gastric cancer patients. A receiver operating characteristics (ROC) curve estimated a maximal sensitivity of 96% at 66% specificity for ITIH3 in gastric cancer detection. In addition, plasma from early stage gastric cancer patient has significantly (p < 0.001) higher level of ITIH3 compared to that from noncancer subject. Our data suggest that ITIH3 may be a useful biomarker for early detection of gastric cancer.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515073      PMCID: PMC3760204          DOI: 10.1021/pr100192h

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  32 in total

Review 1.  The human plasma proteome: history, character, and diagnostic prospects.

Authors:  N Leigh Anderson; Norman G Anderson
Journal:  Mol Cell Proteomics       Date:  2002-11       Impact factor: 5.911

2.  PANTHER: a library of protein families and subfamilies indexed by function.

Authors:  Paul D Thomas; Michael J Campbell; Anish Kejariwal; Huaiyu Mi; Brian Karlak; Robin Daverman; Karen Diemer; Anushya Muruganujan; Apurva Narechania
Journal:  Genome Res       Date:  2003-09       Impact factor: 9.043

Review 3.  Inter-alpha-trypsin inhibitor, a covalent protein-glycosaminoglycan-protein complex.

Authors:  Lisheng Zhuo; Vincent C Hascall; Koji Kimata
Journal:  J Biol Chem       Date:  2004-05-19       Impact factor: 5.157

4.  Inhibition of tumor growth and metastatic spreading by overexpression of inter-alpha-trypsin inhibitor family chains.

Authors:  Sébastien Paris; Richard Sesboüé; Bertrand Delpech; Claude Chauzy; Luc Thiberville; Jean-Pierre Martin; Thierry Frébourg; Maryam Diarra-Mehrpour
Journal:  Int J Cancer       Date:  2002-02-10       Impact factor: 7.396

Review 5.  Use of nude mouse xenograft models in prostate cancer research.

Authors:  W M van Weerden; J C Romijn
Journal:  Prostate       Date:  2000-06-01       Impact factor: 4.104

6.  Meta-analysis on the validity of pepsinogen test for gastric carcinoma, dysplasia or chronic atrophic gastritis screening.

Authors:  M Dinis-Ribeiro; G Yamaki; K Miki; A Costa-Pereira; M Matsukawa; M Kurihara
Journal:  J Med Screen       Date:  2004       Impact factor: 2.136

7.  Identification of tumor-associated plasma biomarkers using proteomic techniques: from mouse to human.

Authors:  Hsueh-Fen Juan; Jenn-Han Chen; Wei-Tse Hsu; Su-Ching Huang; Shui-Tein Chen; John Yi-Chung Lin; Yu-Wang Chang; Chih-Yin Chiang; Li-Li Wen; De-Chuan Chan; Yao-Chi Liu; Yu-Ju Chen
Journal:  Proteomics       Date:  2004-09       Impact factor: 3.984

8.  Phosphoproteomic fingerprinting of epidermal growth factor signaling and anticancer drug action in human tumor cells.

Authors:  Yoon-Pin Lim; Lang-Shi Diong; Robert Qi; Brian J Druker; Richard J Epstein
Journal:  Mol Cancer Ther       Date:  2003-12       Impact factor: 6.261

9.  Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls.

Authors:  Bo Zhang; Jian-Ying Chen; Dao-Da Chen; Guo-Bin Wang; Ping Shen
Journal:  World J Gastroenterol       Date:  2004-06-01       Impact factor: 5.742

10.  Development and preliminary evaluation of a multivariate index assay for ovarian cancer.

Authors:  Suraj D Amonkar; Greg P Bertenshaw; Tzong-Hao Chen; Katharine J Bergstrom; Jinghua Zhao; Partha Seshaiah; Ping Yip; Brian C Mansfield
Journal:  PLoS One       Date:  2009-02-25       Impact factor: 3.240

View more
  21 in total

1.  Comparative proteomic analysis of renal tissue in IgA nephropathy with iTRAQ quantitative proteomics.

Authors:  Weiguo Sui; Zhenzhen Cui; Ruohan Zhang; Wen Xue; Minglin Ou; Guimian Zou; Jiejing Chen; Yong Dai
Journal:  Biomed Rep       Date:  2014-07-23

2.  Differential gene expression profile in PBMCs from subjects with AERD and ATA: a gene marker for AERD.

Authors:  Seungwoo Shin; Jong Sook Park; Yoon-Jeong Kim; Taejeong Oh; Sungwhan An; Choon-Sik Park
Journal:  Mol Genet Genomics       Date:  2012-03-29       Impact factor: 3.291

3.  Candidate serum biomarkers for early intestinal cancer using 15N metabolic labeling and quantitative proteomics in the ApcMin/+ mouse.

Authors:  Melanie M Ivancic; Edward L Huttlin; Xiaodi Chen; Jennifer K Pleiman; Amy A Irving; Adrian D Hegeman; William F Dove; Michael R Sussman
Journal:  J Proteome Res       Date:  2013-08-08       Impact factor: 4.466

4.  MicroRNA-122 influences the development of sperm abnormalities from human induced pluripotent stem cells by regulating TNP2 expression.

Authors:  Te Liu; Yongyi Huang; Jianjun Liu; Yanhui Zhao; Lizhen Jiang; Qin Huang; Weiwei Cheng; Lihe Guo
Journal:  Stem Cells Dev       Date:  2013-03-06       Impact factor: 3.272

5.  The concentrations of EGFR, LRG1, ITIH4, and F5 in serum correlate with the number of colonic adenomas in ApcPirc/+ rats.

Authors:  Melanie M Ivancic; Amy A Irving; Kelli G Jonakin; William F Dove; Michael R Sussman
Journal:  Cancer Prev Res (Phila)       Date:  2014-09-08

6.  Discovery of SLC3A2 cell membrane protein as a potential gastric cancer biomarker: implications in molecular imaging.

Authors:  Yixuan Yang; Weiyi Toy; Lee Yee Choong; Peiling Hou; Hassan Ashktorab; Duane T Smoot; Khay Guan Yeoh; Yoon Pin Lim
Journal:  J Proteome Res       Date:  2012-11-26       Impact factor: 4.466

7.  High level of serum AMBP is associated with poor response to paclitaxel-capecitabine chemotherapy in advanced gastric cancer patients.

Authors:  Hao Huang; Yong Han; Jing Gao; Junnan Feng; Lei Zhu; Like Qu; Lin Shen; Chengchao Shou
Journal:  Med Oncol       Date:  2013-10-18       Impact factor: 3.064

8.  Asthma-predictive genetic markers in gene expression profiling of peripheral blood mononuclear cells.

Authors:  Seung Woo Shin; Tae Jeong Oh; Se-Min Park; Jong Sook Park; An Soo Jang; Sung Woo Park; Soo Taek Uh; Sungwhan An; Choon-Sik Park
Journal:  Allergy Asthma Immunol Res       Date:  2011-05-18       Impact factor: 5.764

9.  Identification of differentially expressed serum proteins in gastric adenocarcinoma.

Authors:  Yashwanth Subbannayya; Sartaj Ahmad Mir; Santosh Renuse; Srikanth S Manda; Sneha M Pinto; Vinuth N Puttamallesh; Hitendra Singh Solanki; H C Manju; Nazia Syed; Rakesh Sharma; Rita Christopher; M Vijayakumar; K V Veerendra Kumar; T S Keshava Prasad; Girija Ramaswamy; Rekha V Kumar; Aditi Chatterjee; Akhilesh Pandey; Harsha Gowda
Journal:  J Proteomics       Date:  2015-05-05       Impact factor: 4.044

10.  iTRAQ reveals candidate pancreatic cancer serum biomarkers: influence of obstructive jaundice on their performance.

Authors:  S Tonack; C Jenkinson; T Cox; V Elliott; R E Jenkins; N R Kitteringham; W Greenhalf; V Shaw; C W Michalski; H Friess; J P Neoptolemos; E Costello
Journal:  Br J Cancer       Date:  2013-04-11       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.